Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania

A consensus conference on the role of sentinel node biopsy in breast carcinoma was held in Philadelphia, April 19‐22, 2001. The current report summarizes the deliberations of the group and advances its current guidelines for the integration of this new technique into contemporary clinical practice....

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 94; no. 10; pp. 2542 - 2551
Main Authors Schwartz, Gordon F., Giuliano, Armando E., Veronesi, Umberto
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 15.05.2002
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A consensus conference on the role of sentinel node biopsy in breast carcinoma was held in Philadelphia, April 19‐22, 2001. The current report summarizes the deliberations of the group and advances its current guidelines for the integration of this new technique into contemporary clinical practice.
Bibliography:Fax: (215) 627‐3925
The Consensus Conference Committee members, who were all authors for this article, were: Gordon F. Schwartz (Co‐chair), M.D., M.B.A., Jefferson Medical College; Armando E. Giuliano (Co‐chair), M.D., John Wayne Cancer Institute; Blake Cady, M.D., Womens & Infants Hospital; Luigi Cataliotti, M.D., Policlinico di Pareggi, Florence; Krishna B. Clough, M.D., Institut Curie, Paris; Hiram S. Cody III, M.D., Memorial Sloan‐Kettering Cancer Center; Edward M. Copeland III, M.D., University of Florida College of Medicine; Charles E. Cox, M.D., University of South Florida Moffitt Cancer Center; Gerard M. Doherty, M.D., Washington University School of Medicine; Michael Edwards, M.D., James Brown Cancer Center; Sheldon Feldman, M.D., Cancer Center of Beth Israel Medical Center; Ian S. Fentiman, M.D., Guy's Hospital, London; Kevin Fox, M.D., University of Pennsylvania School of Medicine; Fred Gorstein, M.D., Thomas Jefferson University Hospital; Daniel Hayes, M.D., University of Michigan Comprehensive Cancer Center; Daniel B. Kopans, M.D., Harvard Medical School; Michael D. Lagios, M.D., St. Mary's Medical Center, San Francisco; Robert E. Mansel, M.B.B.S., M.S., University of Wales College of Medicine; Shahla Masood, M.D., University of Florida Health Science Center; David L. Page, M.D., Vanderbilt University Medical Center; Juan Palazzo, M.D., Thomas Jefferson University Hospital; Peter I. Pressman, M.D., Weill Medical College of Cornell University; Emiel J. Th. Rutgers, M.D., Netherlands Cancer Institute; Bruno Salvadori, M.D., Policlinico San Marco, Bergamo; Melvin J. Silverstein, M.D., University of Southern California (USC)/Keck School of Medicine, USC/Norris Comprehensive Cancer Center; Lawrence J. Solin, M.D., University of Pennsylvania School of Medicine; Daniela Terribile, M.D., Università Cattolica Sacro Cuore, Rome; Michael Untch, M.D., University of Munich; Umberto Veronesi, M.D., European Institute of Oncology, Milan; W. A. Waddington, B.Sc., M.Sc., Institute of Nuclear Medicine, University College London; James A. Waldron, M.D., University of Arkansas for Medical Sciences; David J. Winchester, M.D., Northwestern University Medical School.
SourceType-Scholarly Journals-1
ObjectType-News-2
content type line 23
ObjectType-Review-1
ObjectType-Conference-3
ObjectType-Feature-5
ObjectType-Article-4
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.10539